Treatment Update: Latest Developments in Managing High-Risk Chronic Lymphocytic Leukemia

In this interactive text module, Jeffrey P. Sharman, MD, discusses the latest clinical developments on managing high-risk CLL, providing expert perspective on how these data relate to current treatment guidelines and affect treatment decisions for this patient group. Review challenging patient cases with dynamic in-page polls and compare your choices with those of your colleagues.
person default
Jeffrey P. Sharman, MD


In this interactive treatment update module, Jeffrey P. Sharman, MD, discusses new and emerging data and treatment options for managing patients with high-risk chronic lymphocytic leukemia

person default Jeffrey P. Sharman, MD Physicians: maximum of 1.25 AMA PRA Category 1 Credits Released: February 7, 2014 Expiration: February 6, 2015
Jointly sponsored by the Annenberg Center for Health Sciences at Eisenhower and Clinical Care Options, LLC

Annenberg Center for Health Sciences at Eisenhower
39000 Bob Hope Dr
Dinah Shore Bldg.
Rancho Mirage, CA 92270

Alma Perez, Accreditation Specialist
(760) 773-4506
(760) 773-4550 (Fax)

Educational grant provided by:
Genentech BioOncology

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.


Welcome to the CCO site.

You are accessing CCO's educational content today as a Guest user.

If you would like to continue with free, full access to the CCO Web sites, including free CME/CE credits, please click the button below.


More info

CCO’s educational programs are available completely free of charge on the,, and Web sites. Certain features and functions are restricted for Guest users. By consenting to become a full member, you are eligible to receive CME/CE credit or participation certificates from certified activities, to register for CCO’s free live meetings and webinars, and to receive CCO’s email newsletters alerting you to new content. You can unsubscribe from our emails at any time. CCO strictly protects the privacy of our members, according to our privacy policy.

A confirmation email will be sent to . Not You?